Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1326 to 1350 of 2559

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Superior rectal artery embolisation for haemorrhoidsHTG485
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumoursTA539
Neon EEG electrode for EEG monitoring in newbornsMIB155
AlignRT in breast cancer radiotherapyMIB157
Sutureless aortic valve replacement for aortic stenosisHTG483
Dinutuximab beta for treating neuroblastomaTA538
Flu vaccination: increasing uptakeNG103
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasiaHTG482
Intermediate care including reablementQS173
Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDsTA537
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodineTA535
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerTA536
EndometriosisQS172
Community pharmacies: promoting health and wellbeingNG102
Dupilumab for treating moderate to severe atopic dermatitisTA534
Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healingHTG480
Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fracturesHTG481
Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healingHTG479
Mechanical thrombectomy devices for acute ischaemic strokeMIB153
Remote ECG interpretation consultancy services for cardiovascular diseaseMIB152
Superior capsular augmentation for massive rotator cuff tearsHTG477
Transaxial interbody lumbosacral fusion for severe chronic low back painHTG478
Ocrelizumab for treating relapsing–remitting multiple sclerosisTA533
Medicines management for people receiving social care in the communityQS171
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancerTA531

Results per page

  1. 10
  2. 25
  3. 50
  4. All